Abstract

Over the last decade, we have witnessed deep learning's (DL) revolutionizing countless fields ranging from image processing to natural language processing. While most of the earlier applications of DL were well-structured Euclidean domains, recently there has been an increasing desire to extend DL approaches on nonEuclidean data structures such as graphs. This has led to the introduction of Graph Machine Learning (GML), a class of machine learning algorithms that operate on graphs. Graphs are ubiquitous in nature and provide a robust mathematical abstraction for numerous real-life entities including biomolecules and drugs. As a result, the technical advances in the field of GML have attracted keen interest from pharmaceutical companies to explore their usefulness in Computer-Aided Drug Discovery (CADD) tasks. In this article, we systematically review the applications of GML in CADD with a focus on proteins and small drug molecules.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.